ZA974022B - Key intermediates in the manufacture of simvastatin. - Google Patents

Key intermediates in the manufacture of simvastatin.

Info

Publication number
ZA974022B
ZA974022B ZA9704022A ZA974022A ZA974022B ZA 974022 B ZA974022 B ZA 974022B ZA 9704022 A ZA9704022 A ZA 9704022A ZA 974022 A ZA974022 A ZA 974022A ZA 974022 B ZA974022 B ZA 974022B
Authority
ZA
South Africa
Prior art keywords
simvastatin
manufacture
key intermediates
iii
formula
Prior art date
Application number
ZA9704022A
Other languages
English (en)
Inventor
Jag M Khanna
Yatendra Kumar
Rajesh K Thaper
Satyananda Misra
S M Dileep Kumar
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of ZA974022B publication Critical patent/ZA974022B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9704022A 1997-03-13 1997-05-30 Key intermediates in the manufacture of simvastatin. ZA974022B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/816,574 US5763653A (en) 1997-03-13 1997-03-13 Key intermediates in the manufacture of simvastatin

Publications (1)

Publication Number Publication Date
ZA974022B true ZA974022B (en) 1997-12-09

Family

ID=25221008

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704022A ZA974022B (en) 1997-03-13 1997-05-30 Key intermediates in the manufacture of simvastatin.

Country Status (9)

Country Link
US (1) US5763653A (cs)
EP (1) EP0864560B1 (cs)
AT (1) ATE209627T1 (cs)
CZ (1) CZ286576B6 (cs)
DE (1) DE69708591T2 (cs)
ES (1) ES2166932T3 (cs)
SI (1) SI9700203A (cs)
SK (1) SK282909B6 (cs)
ZA (1) ZA974022B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0940395A1 (en) * 1998-03-05 1999-09-08 Synthon B.V. Process for producing simvastatin and/or its derivatives
SI20070A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nove soli inhibitorjev HMG-CoA reduktaze
AU1683000A (en) * 1998-12-10 2000-06-26 Kaneka Corporation Process for producing simvastatin
CO5140104A1 (es) * 1999-02-16 2002-03-22 Novartis Ag Derivados de mevinolina y preparacion farmaceuticas que los contienen
US6573385B1 (en) 1999-11-11 2003-06-03 Biocon India Limited Process for manufacturing simvastatin and novel intermediates thereof
US6573392B1 (en) 1999-11-11 2003-06-03 Biocon India Limited Process for manufacturing simvastatin and the novel intermediates
WO2002024675A1 (en) * 2000-09-13 2002-03-28 Biocon India Limited Process for manufacturing simvastatin and the novel intermediates
KR100502833B1 (ko) * 2002-03-25 2005-07-25 보령제약 주식회사 심바스타틴 및 이의 중간체 화합물들의 개선된 제조방법
SI21187A (sl) 2002-03-26 2003-10-31 Krka, Tovarna Zdravil D.D., Novo Mesto Postopek za pripravo 4-oksitetrahidropiran-2-onov
US6603022B1 (en) 2002-05-10 2003-08-05 Biocon India Limited Process for manufacturing Simvastatin and novel intermediates thereof
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
CA2515179A1 (en) * 2003-02-11 2004-08-26 Ferenc Korodi Process for preparing simvastatin having controlled ranges of simvastatin dimer content
KR20040092790A (ko) * 2003-04-29 2004-11-04 씨제이 주식회사 심바스타틴 중간체 제조방법
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
CN1754870A (zh) * 2004-09-30 2006-04-05 淮北市辉克药业有限公司 辛伐他汀的制备方法
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
WO2011041231A1 (en) 2009-09-30 2011-04-07 Codexis, Inc. Variant lovd polypeptides and their uses
SG10201504099WA (en) 2009-10-08 2015-06-29 Univ California LovD MUTANTS EXHIBITING IMPROVED PROPERTIES TOWARDS SIMVASTATIN SYNTHESIS

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (cs) * 1974-06-07 1981-03-18
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4293496A (en) * 1980-02-04 1981-10-06 Merck & Co., Inc. 6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4450171A (en) * 1980-08-05 1984-05-22 Merck & Co., Inc. Antihypercholesterolemic compounds
US4582915A (en) * 1983-10-11 1986-04-15 Merck & Co., Inc. Process for C-methylation of 2-methylbutyrates
US4584389A (en) * 1983-10-11 1986-04-22 Merck & Co., Inc. Processes for preparing 6(R)-[2-[8(S)(2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-decahydronaphthyl-1(S)]ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
US4611081A (en) * 1985-07-05 1986-09-09 Merck & Co., Inc. Process for the preparation of HMG-CoA reductase inhibitors intermediates
US4820850A (en) * 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US4908452A (en) * 1987-12-21 1990-03-13 Merck & Co., Inc. Process for preparing nitriles
US5223415A (en) * 1990-10-15 1993-06-29 Merck & Co., Inc. Biosynthetic production of 7-[1',2',6',7',8',8a'(R)-hexahydro-2'(S),6'(R)-dimethyl-8'(S)-hydroxy-1'(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid)
US5159104A (en) * 1991-05-01 1992-10-27 Merck & Co., Inc. Process to simvastatin ester
US5393893A (en) * 1993-11-08 1995-02-28 Apotex, Inc. Process for producing simvastatin and analogs thereof

Also Published As

Publication number Publication date
EP0864560B1 (en) 2001-11-28
ES2166932T3 (es) 2002-05-01
EP0864560A1 (en) 1998-09-16
CZ265097A3 (cs) 1998-09-16
SK116597A3 (en) 1999-05-07
ATE209627T1 (de) 2001-12-15
SI9700203A (sl) 1998-10-31
CZ286576B6 (cs) 2000-05-17
US5763653A (en) 1998-06-09
DE69708591T2 (de) 2002-08-01
DE69708591D1 (de) 2002-01-10
SK282909B6 (sk) 2003-01-09

Similar Documents

Publication Publication Date Title
ZA974022B (en) Key intermediates in the manufacture of simvastatin.
DE69831868D1 (en) Antithrombosemittel
IL133623A0 (en) Antithrombotic agents
EP1193270A3 (en) Pyrrolobenzodiazepines
AU3213795A (en) Endothelin antagonists
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
WO1996032003A3 (en) Tetrahydroimidazopyridoindolediones and their use as medicaments
AU2922295A (en) Use of 2-{(dihydro)pyrazolyl-3'-oxymethylene}-anilides as pest-control agents and fungicides
AU2364600A (en) Heteroroaromatic amides as inhibitor of factor xa
ZA9710796B (en) Oxyiminopregnanecarbolactones.
AU2055500A (en) Aromatic amides
AU2054700A (en) Antithrombotic amides
CA2245587A1 (en) Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
TW334430B (en) Preparation process for benzoyl derivatives and its intermediates
CA2269217A1 (en) New 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives
AU4912090A (en) Intermediates useful in the synthesis of 2-oxy-4h-3, 1-benzoxazin-4-one derivative
CA2256514A1 (en) Veterinary use of a pleuromutilin derivative
AU4600200A (en) Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof
IL111966A0 (en) 4-Benzoylisoxazole derivatives, their preparation and herbicidal compositions containing them
MXPA00012177A (es) Derivados de hiperforina, uso de los mismos y formulaciones que los contienen.
AU4498799A (en) Method of preparing 5- or 8-bromoisoquinoline derivatives
AU2002365378A1 (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
CA2286013A1 (en) Process for making a butylthio-isoquinoline and intermediates therefor
IL107242A0 (en) Derivatives of benzeneborinic acid, preparation thereof and use thereof as synthetic intermediates
IT1313665B1 (it) Processo per la produzione di7alfa-alchil-17beta-idrossi-19-norpregn-5(10)